Back
Regions Financial Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
45
RF
Regions Financial
Last Price:
18.90
Seasonality Move:
2.28%
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
33.09
Seasonality Move:
6.63%
Sell
45
Regions Financial (RF)
is a Sell
Is Regions Financial a Buy, Sell or Hold?
- The current Regions Financial [RF] share price is $19.02. The Score for RF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- RF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $33.15. The Score for MIRM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RF Stock Price Chart
What is Regions Financial's stock price today?
-
The Regions Financial share price today is $19.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RF is experiencing selling pressure, which indicates risk of future bearish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $33.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.
RF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 49.98 | Sell |
Chaikin Money Flow: | -5565365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.53 - 19.35) | Buy |
Bollinger Bands (100): | (18.49 - 19.93) | Sell |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.01 | Buy |
Relative Strength Index (14 RSI): | 64.44 | Buy |
Chaikin Money Flow: | -648557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.98 - 30.18) | Buy |
Bollinger Bands (100): | (24.4 - 28.72) | Buy |
RF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.93 | Buy |
20-day SMA: | 18.81 | Buy |
50-day SMA: | 19.26 | Sell |
200-day SMA: | 18.22 | Buy |
8-day EMA: | 18.95 | Buy |
20-day EMA: | 18.96 | Buy |
50-day EMA: | 19.15 | Sell |
200-day EMA: | 18.88 | Buy |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.76 | Buy |
20-day SMA: | 27.49 | Buy |
50-day SMA: | 25.93 | Buy |
200-day SMA: | 28.17 | Buy |
8-day EMA: | 31.17 | Buy |
20-day EMA: | 28.66 | Buy |
50-day EMA: | 27.01 | Buy |
200-day EMA: | 27 | Buy |
Regions Financial Earnings Growth & RF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.25 per share, and an increase next year of $0.22 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
Regions Financial Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |